Brenda McDermott

Immunoassay Development Scientist at ALPCO

Brenda McDermott is an experienced Immunoassay Development Scientist at ALPCO, with a focus on developing and implementing new products from concept to market within US and European regulatory frameworks since July 2013. Prior to this role, Brenda held positions as a Scientist at AstraZeneca, where contributions were made to oncology research through in-vitro biology, and at Praecis Pharmaceuticals and ImmuLogic Pharmaceutical Corporation as a Scientist and Senior Research Associate, respectively. Brenda holds a Bachelor of Arts degree in Biology from Susquehanna University, attained in 1986.

Location

Danvers, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


ALPCO

American Laboratory Products offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care.


Employees

11-50

Links